Email not displaying properly? View email in your browser
Vertical-Talk Healthcare   Time-to-event Analysis
mRNA Platforms
Pancreatic Cancer
  July 2023   e-Newsletter Advertise | Editorial Calendar 
Klöckner Pentaplast
Latest e-Book


 Editorial Calendar

Author Guidelines
Articles
  Demystifying Lead-time bias and Length-time bias in Clinical Trials
Jefry Winner G, Doctorate of Medicine in Pharmacology JIPMER Puducherry
The use of time-to-event analysis is common in clinical research. The interpretation of time-to-event analysis can often be misleading. Beginners and early career researchers struggle to grasp the concepts and nuances in a time-to-event analysis. The concepts of censoring, truncation, and bias related to time-to-event analysis are essential...
 
Interviews
> mRNA Platforms as Diagnostics and Therapeutics for Human...
Junaid Kashir, ssociate Professor, Department of Biology, Khalifa University
News
HaemaLogiX Enters into Agreement with Peter...
Fapon Launches Chemiluminescence...
Techno Trends
 Merus Discovered Novel Zenocutuzumab (Zeno) for the treatment...
 Thermo Fisher Scientific Discovered Novel Immunoassays for...
 Ascentage Pharma Developed Novel Olverembatinib Drug Candidate...
Medical Fair Thailand 2023
Press Releases
InnoCare Announces Approval of Clinical Trial...
Astellas and PeptiDream Enter into Research...
Projects
 TriLink BioTechnologies to Open mRNA Manufacturing Facility
 WuXi Biologics Expands Drug Manufacturing Capacity
 Novo Nordisk Invests US$2.3 billion (DKK 15.9 billion) to Expand...
Events
21 - 23 Aug 2023
PHARMAFORUM2023
30 - 01 Aug 2023
CPHI Korea 2023
Research Insights
  Long-read Sequencing Identifies Novel Structural Variations in...
 The Emotional Side of Taking Part in a Cancer Clinical Trial
 Isolation of Salivary Cell-free DNA for Cancer Detection
  Subscribe  |  e-book Archives  | Advisory Board  
Follow Us Facebook Facebook Facebook
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.